Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4518941000168118 | Kabiven G19% (alanine 9.6 g / 2.053 L + arginine 6.8 g / 2.053 L + aspartic acid 2 g / 2.053 L + calcium chloride dihydrate 590 mg / 2.053 L + glutamic acid 3.4 g / 2.053 L + glycine 4.7 g / 2.053 L + histidine 4.1 g / 2.053 L + isoleucine 3.4 g / 2.053 L + leucine 4.7 g / 2.053 L + lysine hydrochloride 6.8 g / 2.053 L + magnesium sulfate heptahydrate 2 g / 2.053 L + methionine 3.4 g / 2.053 L + phenylalanine 4.7 g / 2.053 L + potassium chloride 3.6 g / 2.053 L + proline 4.1 g / 2.053 L + serine 2.7 g / 2.053 L + sodium acetate trihydrate 4.9 g / 2.053 L + sodium glycerophosphate 3 g / 2.053 L + threonine 3.4 g / 2.053 L + tryptophan 1.1 g / 2.053 L + tyrosine 140 mg / 2.053 L + valine 4.4 g / 2.053 L) injection [1 x 600 mL chamber] (&) (glucose 200 g / 2.053 L) injection [1 x 1.053 L chamber] (&) (soya oil 80 g / 2.053 L) injection [1 x 400 mL chamber], 4 x 2.053 L multi-chamber bags (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4518951000168116 | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | Is a | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has container type | multi-chamber bag | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has TP | Kabiven G19% | true | Inferred relationship | Some | ||
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has TPUU | Kabiven G19% Glucose 200 g/2.053 L injection, 1.053 L chamber | true | Inferred relationship | Some | 1485957958 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has TPUU | Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | true | Inferred relationship | Some | 902764189 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has subpack | Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 2.053 L multi-chamber bag | true | Inferred relationship | Some | 2055498599 | |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has TPUU | Kabiven G19% Vamin 18 Novum injection, 600 mL chamber | true | Inferred relationship | Some | 280830047 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR